Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows selective modification to enhance binding affinity to specific enzyme targets. Commonly employed in research settings to design drugs targeting protein kinases involved in tumor growth and inflammation. Also utilized in the preparation of novel heterocyclic compounds for biological activity screening in drug discovery programs.